Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Aldeyra_Therapeutics
|
| gptkbp:advertising |
global reach
|
| gptkbp:businessModel |
strategic alliances
biopharmaceutical development |
| gptkbp:CEO |
gptkb:David_R._Guyer
|
| gptkbp:challenges |
competitive landscape
|
| gptkbp:clinicalTrials |
Phase 2
Phase 3 ongoing studies retinal diseases biopharmaceutical company positive results novel treatments |
| gptkbp:collaborations |
academic institutions
research institutions international partners leading hospitals |
| gptkbp:community_engagement |
patient advocacy
|
| gptkbp:community_involvement |
patient education programs
|
| gptkbp:community_service |
vision improvement
|
| gptkbp:enrollment |
diverse demographics
|
| gptkbp:feedback |
measurable improvements
|
| gptkbp:financialPerformance |
publicly traded
|
| gptkbp:focus |
ophthalmic diseases
|
| gptkbp:focus_area |
retinal diseases
|
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:David_R._Guyer
|
| gptkbp:funding |
grants and investments
|
| gptkbp:future_plans |
market leadership
promising developments expand pipeline |
| gptkbp:headCoach |
growing team
|
| gptkbp:headquarters |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Iveric Bio
|
| gptkbp:investmentFocus |
R&D
venture capital firms transparent communication |
| gptkbp:leadership |
experienced team
|
| gptkbp:leads |
Zimura_(avacincaptad_pegol)
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
ophthalmology
growing visibility |
| gptkbp:mission |
improve vision
|
| gptkbp:partnerships |
gptkb:Astellas_Pharma
biopharma companies |
| gptkbp:platforms |
biologics
|
| gptkbp:products |
Zimura
patient-centric approach |
| gptkbp:publications |
peer-reviewed journals
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
strict adherence FDA_filings |
| gptkbp:research |
gene therapy
ongoing investigations |
| gptkbp:research_areas |
cutting-edge research
complement inhibition age-related macular degeneration multiple indications |
| gptkbp:specialties |
ophthalmic specialists
|
| gptkbp:stockSymbol |
gptkb:ISEE
|
| gptkbp:supportRole |
experts in ophthalmology
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:tributaryOf |
multiple drug candidates
|
| gptkbp:type |
public company
|
| gptkbp:vision |
innovative therapies
|
| gptkbp:website |
www.ivericbio.com
|